| Aldagen Announces Positive Phase 1/2 Results For Critical Limb Ischemia Stem Cell Therapy ALD-301 |
| Aldagen today announced positive results from its multicenter Phase 1/2 clinical trial of ALD-301, a novel stem cell therapy being developed for the treatment of critical limb ischemia. In the 24-week Phase 1/2 trial, ALD-301 was well tolerated.
11/21/2008
|
| Adult Stem Cells - Biology And Clinical Applications Conference, Griffith University, Australia |
| The National Centre for Adult Stem Cell Research looks forward to welcoming delegates to the first Adult Stem Cell - Biology and Clinical Applications Conference from the 26-28 November 2008 at the Ian Hanger Recital Hall, Queensland Conservatorium of Music, Griffith University.
11/20/2008
|
| Stem Cell Pilot Study Tackles Devastating Genetic Paraplegia |
| BRISBANE'S National Centre for Adult Stem Cell Research will commence a pilot study into a devastating genetic disease in which active young people progressively develop paraplegia. The little-known disease, Hereditary Spastic Paraplegia, has about 1000 diagnosed sufferers in Australia, but the mutations responsible may lurk in the genes of an unknown percentage of the population.
11/20/2008
|
| BioTime CEO Dr. Michael West Discusses State Of Stem Cell Industry Under Obama Administration At Wisconsin Academy Of Sciences, Arts, And Letters |
| BioTime, Inc. (OTCBB:BTIM) Chief Executive Officer Michael West, Ph.D. delivered the keynote presentation on Wednesday, November 19, at a meeting in Madison, Wisconsin commemorating the 10th anniversary of the publication describing the first derivation and culturing of human embryonic stem cells. Dr. West's presentation is titled "Opportunities and Challenges of Commercializing Stem Cell Research.
11/20/2008
|
| Stem Cell Collection For Parkinson's Disease Therapy: Jefferson Researchers Define Ideal Time |
| Researchers have identified a stage during dopamine neuron differentiation that may be an ideal time to collect human embryonic stem cells for transplantation to treat Parkinson's disease, according to data presented at Neuroscience 2008, the 38th annual meeting of the Society for Neuroscience. Lorraine Iacovitti, Ph.D.
11/20/2008
|
| Jumonjd3: A Molecular Key For Unlocking Neuronal Stem Cell Fate |
| A protein called Jumonjd3 has been identified by scientists at the IFOM-IEO Campus, Milan, Italy, as the molecular key required for starting up the differentiation process and for issuing neuronal "identity cards" to embryonic stem cells.
11/20/2008
|
| 2nd Annual Stem Cell Symposium At UNSW, Australia |
| Friday 28 November, 2008 Edumund Blacket Building, Prince of Wales Hospital Cost: Free for UNSW staff and students; others $80 / $30-students This full day symposium shows the breadth of stem cell research being carried out across various stem cell disciplines at the
11/20/2008
|
| Janet Rossant To Deliver Annual Dame Anne McLaren Memorial Lecture - National Stem Cell Network |
| The UK National Stem Cell Network (UKNSCN) has announced that Professor Janet Rossant, one of the world's foremost developmental biologists from The Hospital for Sick Children in Toronto, will deliver the second annual Dame Anne McLaren Memorial Lecture. The Lecture is the principal keynote address of the UKNSCN's annual research conference, being next year in Oxford, 6-8 April.
11/20/2008
|
| Stem Cell Research In Cardiology - A Report By Research And Markets |
| This report specifies the importance of Stem Cell Research in Cardiology. The study is segmented by Source (Allogenic and Autogenic) and by Type (Bone Marrow Stem Cells, Embryonic Stem Cells, and Other). Projections and estimates are graphically illustrated by geographic region encompassing North America, Europe, Asia-Pacific, and Rest of World. Business profiles of 23 major companies are discussed in the report.
11/20/2008
|
| Tissue Genesis Applies CE Mark To Its Adult Stem Cell Isolation System |
| Tissue Genesis, Inc., an innovator of advanced tissue engineering and cell therapy solutions, today announced that effective immediately, the Tissue Genesis Cell Isolation System will be available to the European marketplace. The Tissue Genesis Cell Isolation System is a fully automated system that recovers potentially regenerative cells from a patient's own fat in about an hour, with minimal operator intervention. No tissue pre-processing is required.
11/20/2008
|
| Global Research Leaders To Speak At UK's National Stem Cell Conference |
| Professor Robert Nerem and Dr Joseph Vacanti, world leading researchers in tissue engineering and organ transplantation respectively, have been confirmed to deliver keynote talks at the UK National Stem Cell Network (UKNSCN) Annual Conference in Oxford, 6-8 April 2009. They will join the already announced Professor.Janet Rossant, a leading developmental and stem cell biologist, as the conference keynote speakers.
11/20/2008
|
| Neurons Derived From Embryonic Stem Cells Restore Muscle Function After Injury |
| Dalhousie Medical School researchers have discovered that embryonic stem cells may play a critical role in helping people with nerve damage and motor neuron diseases, such as amyotrophic lateral sclerosis (ALS), regain muscular strength. Motor neurons reside in the spinal cord and control limb movements by enabling muscles to contract. Diseases like ALS cause them to degenerate, resulting in muscle weakness, atrophy, and eventual paralysis.
11/20/2008
|
| Researchers Define Ideal Time For Stem Cell Collection For Parkinson's Disease Therapy |
| Researchers have identified a stage during dopamine neuron differentiation that may be an ideal time to collect human embryonic stem cells for transplantation to treat Parkinson's disease, according to data presented at Neuroscience 2008, the 38th annual meeting of the Society for Neuroscience. Lorraine Iacovitti, Ph.D.
11/20/2008
|
| Exercise Helps Increase Production Of Neural Stem Cells In Mice Brains |
| A new study confirms that exercise can reverse the age-related decline in the production of neural stem cells in the hippocampus of the mouse brain, and suggests that this happens because exercise restores a brain chemical which promotes the production and maturation of new stem cells. Neural stem cells and progenitor cells differentiate into a variety of mature nerve cells which have different functions, a process called neurogenesis.
11/19/2008
|
| Maryland Stem Cell Research Commission Receives Strong Interest In Third Year Of Funding |
| The Maryland Stem Cell Research Commission (Commission) has received 187 Letters of Intent in response to its three official Requests for Applications (RFAs) for the third year of funding through the Maryland Stem Cell Research Fund (MSCRF) under the Maryland Stem Cell Research Act of 2006. The Commission plans to issue a Request for Information (RFI) to seek ideas and suggestions for new grants for shared resources to be funded by the MSCRF in the near future.
11/19/2008
|
